Production (Stage)
Bellicum Pharmaceuticals, Inc.
BLCM
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.91M | 7.41M | 15.40M | 21.84M | 28.76M |
| Total Receivables | 15.00K | -- | 8.00K | -- | 1.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 924.00K | 1.30M | 1.83M | 1.96M | 1.51M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.85M | 8.71M | 17.24M | 23.80M | 31.27M |
|
|
|||||
| Total Current Assets | 6.85M | 8.71M | 17.24M | 23.80M | 31.27M |
| Net Property, Plant & Equipment | 5.00K | 21.00K | 24.00K | 22.00K | 17.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.85M | 8.73M | 17.26M | 23.82M | 31.28M |
|
|
|||||
| Total Accounts Payable | 526.00K | 472.00K | 1.23M | 486.00K | 714.00K |
| Total Accrued Expenses | 1.21M | 2.49M | 3.26M | 2.48M | 3.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 518.00K | 523.00K | 235.00K | 809.00K | 1.95M |
| Total Other Current Liabilities | 518.00K | 523.00K | 235.00K | 809.00K | 1.95M |
| Total Current Liabilities | 2.25M | 3.48M | 4.72M | 3.77M | 5.75M |
|
|
|||||
| Total Current Liabilities | 2.25M | 3.48M | 4.72M | 3.77M | 5.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.25M | 3.48M | 4.72M | 3.77M | 5.75M |
|
|
|||||
| Common Stock & APIC | 570.00M | 574.41M | 578.88M | 582.85M | 582.14M |
| Retained Earnings | -591.61M | -590.84M | -583.49M | -575.43M | -569.23M |
| Treasury Stock & Other | -5.41M | -5.41M | -5.41M | -5.41M | -5.41M |
| Total Common Equity | -27.01M | -21.84M | -10.02M | 2.02M | 7.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 31.62M | 27.09M | 22.56M | 18.04M | 18.04M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 31.62M | 27.09M | 22.56M | 18.04M | 18.04M |
|
|
|||||
| Total Common Equity | -27.01M | -21.84M | -10.02M | 2.02M | 7.50M |
| Total Preferred Equity | 31.62M | 27.09M | 22.56M | 18.04M | 18.04M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.60M | 5.25M | 12.54M | 20.05M | 25.54M |
|
|
|||||